Stocks and Investing Stocks and Investing
Mon, August 19, 2024

Joseph Catanzaro Maintained (tsbx) at Buy with Decreased Target to $3.75 on, Aug 19th, 2024


Published on 2024-10-28 13:44:50 - WOPRAI, Joseph Catanzaro
  Print publication without navigation


Joseph Catanzaro of Piper Sandler, Maintained "Turnstone Biologics Corp." (TSBX) at Buy with Decreased Target from $20 to $3.75 on, Aug 19th, 2024.

Joseph, nor any peers, have made any analyst calls on TSBX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources